Pterostilbene as a pyroptosis inducer and tumor microenvironment regulator inhibits glioblastoma and enhances the efficacy of immunotherapy
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115247 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Zhuo Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Hubei Key Laboratory of Embryonic Stem Cell Research, Ta…. Hauptthemen laut MEDLINE: Pyroptosis, Glioblastoma, Stilbenes, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hubei University of Medicine, Natural Science Foundation of Hubei Province, Science and Technology Program of Hubei Province.
Abstract (Originalsprache)
Glioblastoma (GBM) is a highly invasive tumor type associated with a high mortality rate, and the efficacy of traditional chemotherapy, targeted therapy, and immunotherapy for GBM remains limited. Therefore, there is an urgent need to develop novel therapeutic agents and strategies to combat GBM effectively. The upregulation of the pivotal pyroptosis protein GSDME in GBM suggests that harnessing cellular pyroptosis may be a promising approach for anti-GBM treatment. This study revealed that the natural polyphenol pterostilbene (PTE) induces pyroptosis and inhibits proliferation in GBM cells. Network pharmacology, western blot analysis, LDH release experiments, and damage-associated molecular pattern (DAMP) detection collectively confirmed that PTE triggers CASP3/GSDME-dependent pyroptosis but not GSDMD-dependent pyroptosis in GBM cells. Molecular docking, RNA-seq, microscale thermophoresis (MST), and western blot analyses revealed that PTE inhibited STAT3 activation while activating a potential regulatory loop dependent on mitochondrial reactive oxygen species (ROS) accumulation to initiate the CASP3/GSDME pathway and promote cell pyroptosis. PTE treatment exerts direct antitumor effects by inducing both apoptosis and pyroptosis in glioblastoma (GBM) cells. Furthermore, it upregulates the expression of pro-inflammatory factors within tumor tissues, enhances the infiltration of CD8+ T cells in both the tumor microenvironment and spleen, increases the proportion of M1-type tumor-associated macrophages (TAMs), and decreases the proportion of regulatory T cells (Tregs) in the tumor microenvironment, thereby effectively reversing the immunosuppressive milieu. Further investigations showed that combining PTE with immune checkpoint inhibitors aPD-1 enhanced the infiltration of potent antitumor immune cells, significantly inhibiting mouse tumor growth and prolonging survival. Our study provides a new mechanistic basis for the therapeutic development of PTE as a pyroptosis inducer in the GBM tumor microenvironment that can enhance the efficacy of aPD-1 immunotherapy, opening new possible avenues for the treatment of this high-mortality tumor type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Wuha…
- Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Neur…
- Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China.
Förderung
- Hubei University of Medicine
- Natural Science Foundation of Hubei Province
- Science and Technology Program of Hubei Province
- Hubei Provincial Department of Education
- National Natural Science Foundation of China
- Health Commission of Hubei Province
Zitieren
APA
Chen, Z., Fang, X. G., Jia, L. J., Feng, Y., Cheng, J. H., Luo, S., Wen, S., Wei, J. R., Ma, S. N., Guo, X. R., & Luo, J. (2025). Pterostilbene as a pyroptosis inducer and tumor microenvironment regulator inhibits glioblastoma and enhances the efficacy of immunotherapy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115247
Vancouver
Chen Z, Fang XG, Jia LJ, Feng Y, Cheng JH, Luo S, et al. Pterostilbene as a pyroptosis inducer and tumor microenvironment regulator inhibits glioblastoma and enhances the efficacy of immunotherapy. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115247
BibTeX
@article{Chen2025,
author = {Chen, Zhuo and Fang, Xing-Gang and Jia, Lu-Jia and Feng, Ying and Cheng, Jun-Hua and Luo, Shan and Wen, Shu and Wei, Jia-Rui and Ma, Shi-Nan and Guo, Xing-Rong and Luo, Jie},
title = {Pterostilbene as a pyroptosis inducer and tumor microenvironment regulator inhibits glioblastoma and enhances the efficacy of immunotherapy},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115247}
}
EUVIMED